Because the other epilepsy drugs carry similar risks. So they leave it as an option since the individual risk profile depends on the effectiveness and efficacy

Because the other epilepsy drugs carry similar risks. So they leave it as an option since the individual risk profile depends on the effectiveness and efficacy of the other drugs for that specific person. Even the "safe" standard (keppra) has these risks today.